Blindsided: challenging the dogma of masking in clinical trials.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial.International journal of stroke : official journal of the International Stroke Society · 2023
   Trial
2. SAS macro programme for Bang's Blinding Index to assess and visualise the success of blinding in randomised controlled trials.General psychiatry · 2024
   Review
3. Protecting blinded trials in electronic hospital systems.Clinical trials (London, England) · 2022
   Article
4. Natural unblinding of BCG vaccination trials.Vaccine · 2021
   Article
5. Blinding Assessment: One Step Forward.Dental hypotheses
   Article

Corrections and comments

• Comment on
  Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as